Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 7/11/12  and contains information from public web pages.

Dr. Luca Vangelista

Wrong Dr. Luca Vangelista?

Independent Scientist

Local Address: Italy
San Raffaele Scientific Institute
3 Rancho San Diego Animal Hospital
El Cajon, California 92019
United States

Company Description: Il 5 x 1000 è una grande opportunità per sostenere la Ricerca Sanitaria della Fondazione San Raffaele. I grandi risultati degli anni passati ci hanno permesso di...   more
Background

Employment History

7 Total References
Web References
AllergoOncology Portal - Luca Vangelista
www.allergooncology.org, 11 July 2012 [cached]
Luca Vangelista AllergoOncology Portal - Luca Vangelista
...
Luca Vangelista
...
Dr. Luca Vangelista San Raffaele Scientific Institute
...
Dr. Luca Vangelista spent over a decade in several European laboratories, in the commitment to characterize molecular and structural biology aspects of IgE, FceRI and recombinant allergens. In 2003 he moved to Milan where he joined Prof. Antonio Siccardi as an independent Scientist at the San Raffaele Scientific Institute and the Department of Biology and Genetics of the University of Milan. He is developing innovative strategies to combat tumors using exogenous IgE and its derivatives and is investigating the role of endogenous IgE in tumor surveillance.
E A A C I
www.eaaci.net, 19 Feb 2007 [cached]
Luca Vangelista, University of Milano
Finally, in experiments combining both ...
www.aidsmap.org, 4 Mar 2008 [cached]
Finally, in experiments combining both approaches, Luca Vangelista of the San Raffaele Scientific Institute in Italy has engineered the same lactobacilli as in the Xu study to produce human-type RANTES and is currently engineering another variant that will produce an analogue called C1C5-RANTES, and also small peptides - sections - derived from RANTES to see if these have anti-HIV activity.
BCPWA HIV/AIDS eNews - March 14, 2008
bcpwa.baremetal.com, 14 Mar 2008 [cached]
Finally, in experiments combining both approaches, Luca Vangelista of the San Raffaele Scientific Institute in Italy has engineered the same lactobacilli as in the Xu study to produce human-type RANTES and is currently engineering another variant that will produce an analogue called C1C5-RANTES, and also small peptides , sections , derived from RANTES to see if these have anti-HIV activity.
Luca Vangelista ...
www.allergooncology.org, 23 April 2007 [cached]
Luca Vangelista
...
Luca VangelistaDr. Luca Vangelista spent over a decade in several European laboratories, in the commitment to characterize molecular and structural biology aspects of IgE, FceRI and recombinant allergens.In 2003 he moved to Milan where he joined Prof. Antonio Siccardi as an independent Scientist at the San Raffaele Scientific Institute and the Department of Biology and Genetics of the University of Milan.He is developing innovative strategies to combat tumors using exogenous IgE and its derivatives and is investigating the role of endogenous IgE in tumor surveillance.
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304